SEC Filing Details

SEC Filing Details

Document Details

Form
4/A
Filing Date
Aug 29, 2018
Document Date
Jun 13, 2018
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
ReShape Lifesciences
Issuer
RESHAPE LIFESCIENCES INC.
Filer
MOATAZEDI DAVID
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE